NVCR financials
NovoCure (NVCR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
NVCR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $655.35M | $488.47M | -$153.80M | -$136.23M | -1.22 |
| 2024 | $605.22M | $468.04M | -$170.50M | -$168.63M | -1.56 |
| 2023 | $509.34M | $381.06M | -$232.87M | -$207.04M | -1.95 |
| 2022 | $537.84M | $422.97M | -$89.52M | -$92.53M | -0.88 |
| 2021 | $535.03M | $420.15M | -$44.33M | -$58.35M | -0.56 |
| 2020 | $494.37M | $387.87M | $30.40M | $19.81M | 0.18 |
- NVCR revenue was $655.35M in fiscal 2025, net income -$136.23M.
Updated 2026-11-03 13:30 UTC